HomeQuestion

Given recent OS data from the OlympiA trial, would you offer adjuvant olaparib to a BRCA+ patient with pT1bN0 TNBC?

1 Answers

Mednet Member

Medical Oncology · Sarah Cannon Cancer Institute at Menorah Medical Center

I would not, as those patients were not included in OlympiA.

Given recent OS data from the OlympiA trial, would you offer adjuvant olaparib to a BRCA+ patient with pT1bN0 TNBC? | Mednet